Evidence-Base Management of Esophageal and Gastric Varices
|
|
- Elfrieda Higgins
- 5 years ago
- Views:
Transcription
1 Evidence-Base Management of Esophageal and Gastric Varices Rino Alvani Gani Hepatobiliary Division Department of Internal Medicine Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo National General Hospital
2 Chronic Liver Disease Chronic liver disease Compensated cirrhosis Decompensated cirrhosis Death Emergence of complications: Ascites Hepatic encephalopathy Icterus Esophageal & gastric varices
3 Liver cirrhosis Portal systemic colateral Increased resistance due to sinusoid disturbance Portal vein Splenomegaly
4 VARICES AND VARICEAL HEMORRHAGE Cirrhosis Resistance to portal flow Portal pressure Varices Variceal Growth
5 VARICES INCREASE IN DIAMETER PROGRESSIVELY VARICES INCREASE IN DIAMETER PROGRESSIVELY No varices Small varices Large varices
6 PREVENTION OF VARICEAL DEVELOPMENT TREATMENT OF VARICES / VARICEAL HEMORRHAGE No varices Prevention of variceal development Varices No hemorrhage Variceal hemorrhage Recurrent hemorrhage
7 NON-SELECTIVE BETA BLOCKERS DO NOT PREVENT DEVELOPMENT OF VARICES PRE-PRIMARY PROPHYLAXIS Multicenter, randomized, placebo-controlled trial of timolol (non-selective beta-blocker) vs. Placebo in patients Beta-blockers did not prevent the development of varices and were associated with a higher rate of serious adverse events Hepatic venous pressure gradient was the strongest predictor of the development of varices
8 MANAGEMENT OF PATIENTS WITHOUT VARICES Treatment of Varices / Variceal Hemorrhage No varices No specific therapy Repeat endoscopy in every 2-3 yrs Varices No hemorrhage Variceal hemorrhage Recurrent hemorrhage
9 PREVENTION OF FIRST VARICEAL HEMORRHAGE Treatment of Varices / Variceal Hemorrhage No varices Varices No hemorrhage Variceal hemorrhage Prevention of first variceal hemorrhage Recurrent hemorrhage
10 MANAGEMENT OF PATIENTS WITH VARICES WHO HAVE NEVER BLED Treatment of Varices / Variceal Hemorrhage No varices Varices No hemorrhage Management depends on the size of varices Variceal hemorrhage Recurrent hemorrhage
11 MANAGEMENT OF PATIENTS WITH SMALL VARICES WITHOUT PRIOR HEMORRHAGE Treatment of Varices / Variceal Hemorrhage No varices Varices No hemorrhage? Prevention of variceal growth Variceal hemorrhage Recurrent hemorrhage
12 MANAGEMENT OF PATIENTS WITH SMALL VARICES WITHOUT PRIOR HEMORRHAGE Treatment of Varices / Variceal Hemorrhage No varices Varices No hemorrhage Repeat endoscopy in 1-2 years Beta-blockers? Variceal hemorrhage Recurrent hemorrhage
13 MANAGEMENT OF PATIENTS WITH MEDIUM/LARGE VARICES WITHOUT PRIOR HEMORRHAGE Treatment of Varices / Variceal Hemorrhage No varices Small varices No hemorrhage Large varices No hemorrhage Variceal hemorrhage 1) -blockers (propranolol 1-2 mg/kg/day) indefinitely 2) Endoscopic variceal ligation/sclerotherapy in patients intolerant to - blockers Recurrent hemorrhage
14 Small varices, compensated cirrhosis Cirrhotic patients + Small varices, red sign or Decompensated cirrhosis + Small varices without red sign NSSB Sarin SK et al, Hepatol Int 2008
15 Patients with no varices or small varices (unchanged) There is no indication, at this time, to use beta blockers to prevent the formation of varices (1b;A) Patients with small varices with red wale marks or CP-C have an increased risk of bleeding (1b;A) and should be treated with nonselective beta blockers (5;D) Patients with small varices without signs of increased risk may be treated with NSBB to prevent bleeding (1b;A). Further studies are required to confirm their benefit.
16 PROPRANOLOL Decreases cardiac output resulting in decreased portal pressure and variceal size. Reduces the intrahepatic portal vascular resistance. MOST WIDELY USED β BLOCKER. Produces splanchnic vasoconstriction which leasd to decrease in portal blood flow. Used along with sclerotherapy. Benificial results in terms of lower rebleeding rates & lower variceal recurrence.
17 Endoscopic Variceal Band Ligation BLEEDING CONTROLLED IN 90% REBLEEDING RATE 30% COMPARED WITH SCLEROTHERAPY: Less rebleeding Lower mortality Fewer complications ENDOSCOPIC VARICEAL BAND LIGATION Fewer treatment sessions
18 Variceal ligation Under direct visualization through an flexible endoscope, elastic bands are applied to oesophageal or gastric varices Indications: Bleeding varices Theraupetic non-bleeding varices
19 EVBL appears to be superior to BB in preventing the first variceal bleed. No difference was found for mortality
20 Overall bleeding Funakoshi M, et al. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Annals of Hepatology 2012; 11 (3):
21 Overall mortality Funakoshi M, et al. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Annals of Hepatology 2012; 11 (3):
22 Patients with medium-large varices (unchanged) Either NSBB or endoscopic band ligation is recommended for the prevention of the first variceal bleeding of medium or large varices (1a;A) The choice of treatment should be based on local resources and expertise, patient preference and characteristics, contraindications and adverse events (5;D)
23 CONTROL OF ACUTE VARICEAL HEMORRHAGE Treatment of Varices / Variceal Hemorrhage No varices Small varices No hemorrhage Medium/ large varices No hemorrhage Variceal hemorrhage Control of hemorrhage Recurrent hemorrhage
24 GENERAL MANAGEMENT: Iv access and fluid resuscitation Do not overtransfuse (hemoglobin ~ 8 g/dl) Antibiotic prophylaxis (iv ceftriaxone mg/kg/day) SPECIFIC THERAPY: Pharmacological therapy: terlipressin, somatostatin and analogues, vasopressin + nitroglycerin Endoscopic therapy: band ligation, sclerotherapy Shunt therapy: tips, surgical shunt
25 PHARMACOLOGIC THERAPY Somatostatin-decreases portal flow, splanchnic vasoconstriction. Octreotide- 50mcg/h shown to reduce complications of bleeding after sclerotherapy. Vasopressin- reduces blood flow to all splanchnic organs, decreases portal pressure, venous blood flow. Use nitroglycerin with it! It s the most potent splanchnic vasoconstrictor. Antibiotics to prevent infection.
26 Terlipressin vs Placebo in Variceal Hemorrhage Meta-analysis of Terlipresin vs Placebo Results even more significant after adding the RCT by Levacher et al (Lancet, 1995)
27 HVPG decrease during active bleeding after somatostatin (250 vs 500 ug/h) or Terlipressin Villanueva et al. Am J Gastroenterology 2006
28 Gastric Varices APASL Recommendation on Management of Acute Variceal Bleeding Acute bleeding from gastric varices tissue adhesive injection is the treatment of choice (1b. A) Sarin SK et al. Hepatol Int 2011
29 Patients with gastric varices (changed from Baveno V) Although a single study suggested that cyanoacrylate injection is more effective than beta blockers in preventing first bleeding in patients with large gastroesophageal varices type 2 or isolated gastric varices type 1 (1b;A), further studies are needed to evaluate the risk/benefit ratio of using cyanoacrylate in this setting before a recommendation can be made
30 TIPS IN THE TREATMENT OF VARICEAL HEMORRHAGE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT Tips is rescue therapy for recurrent variceal hemorrhage It is only useful in portal hypertension of hepatic origin. Tips is indicated in patients who rebleed on combination endoscopic plus pharmacologic therapy In patients with cirrhosis, the distal spleno-renal shunt is as effective as tips.
31 ACCEPTED INDICATIONS Active bleeding despite endoscopic or pharmacologic treatment Recurrent variceal bleeding despite adequate endoscopic treatment. Potential indications include bleeding gastric fundic varices, refractory ascites. A bridge to transplantation.
32 Transjugular Intrahepatic Portosystemic Shunt Hepatic vein TIPS Portal vein Splenic vein Superior mesenteric vein
33 Polytetrafluoroethylene-covered TIPS stent
34 Trials comparing early TIPS and standard treatment (combines pharmaco and endoscopic therapy) in high-risk variceal bleeding Siramolpiwat S, et al. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol 2014; 20(45):
35 Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Preventing gastric variceal rebleeding after endoscopic therapy or when management with endoscopic therapy fails Patel A, et al. Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices. AJR 2012; 199:
36 BRTO (Technique) Garcia-Pagan JC, et al. Management of Gastric Varices. Clinical Gastroenterology and Hepatology 2014;12:
37 Published reports of BRTO Patel A, et al. Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices. AJR 2012; 199:
38 BRTO of Gastric Varices (Patel et al) Although the procedure can be performed when TIPS is contraindicated or when endoscopic management fails, it is successful as a first- or second-line therapy Patel A, et al. Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices. AJR 2012; 199:
39 Studies Utilizing BRTO to Treat Gastric Varices BRTO utilizing STS foam appears effective in obliterating bleeding GV with good short-term outcomes Sabri SS, et al. Bleeding Gastric Varices Obliteration with Balloon- occluded Retrograde Transvenous Obliteration Using Sodium Tetradecyl Sulfate Foam. J Vasc Interv Radiol 2011; 22:
40 Self-Expandable Metal Stents (SEMS) Were mainly used for treatment of esophageal obstruction/strictures, leaks, perforation or even tracheoesophageal fistulas. The first cases of SEMS application for esophageal variceal bleeding were reported eight years ago. SEMSs constructed for variceal bleeding have become commercially available outside of clinical studies. Muller M, et al. Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection- Therapy: A Retrospective Study. PLoS ONE (6): e
41 Muller M, et al. Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection- Therapy: A Retrospective Study. PLoS ONE (6): e
42 Conclusion of the study Self-expandable metal stents for esophageal variceal bleeding seem to be safe and efficient after failed standard therapy. SEMS should be considered a reasonable treatment option for refractory esophageal variceal bleeding after treatment failure of ligature and sclerotherapy or contraindication for other measures (e.g. TIPS). Muller M, et al. Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection- Therapy: A Retrospective Study. PLoS ONE (6): e
43 Use of self-expandable metal stents (changed from Baveno V) Data suggest that self-expanding covered oesophageal metal stents may be as efficacious and a safer option than balloon tamponade in refractory oesophageal variceal bleeding (4;C).
44 Thank You
45 April 2015 J Hepatol 2015 ; 63 :
46 No varices MANAGEMENT OF PATIENTS WITH ACUTE VARICEAL HEMORRHAGE Treatment of Varices / Variceal Hemorrhage Small varices No hemorrhage Medium/ large varices No hemorrhage Variceal hemorrhage Recurrent hemorrhage 1) Safe vasoactive drug + endoscopic therapy + balloon tamponade+antibiotic prophylaxis 2) TIPS / Shunt (rescue therapy)
47 PREVENTION OF RECURRENT VARICEAL HEMORRHAGE Treatment of Varices / Variceal Hemorrhage No varices Varices No hemorrhage Variceal hemorrhage Recurrent hemorrhage 1) -blockers + EVL 2)TIPS / shunt surgery
48 SUMMARY OF MANAGEMENT OF VARICES AND VARICEAL HEMORRHAGE Evolution of Varices Cirrhosis with no varices Level of Intervention Pre-primary prophylaxis Management Recommendations Repeat endoscopy in 2-3 years No specific therapy
49 SUMMARY OF MANAGEMENT OF VARICES AND VARICEAL HEMORRHAGE Evolution of Varices Cirrhosis with no varices Small varices No hemorrhage Medium / large varices No hemorrhage Level of Intervention Pre-primary prophylaxis Primary prophylaxis Management Recommendations Repeat endoscopy in 2-3 years No specific therapy Small varices Repeat endoscopy in 1-2 years No specific therapy? beta-blocker to prevent enlargement Medium/Large varices Non-selective beta-blockers EVL in those intolerant to drugs
50 SUMMARY OF MANAGEMENT OF VARICES AND VARICEAL HEMORRHAGE Evolution of Varices Cirrhosis with no varices Small varices No hemorrhage Medium / large varices No hemorrhage Variceal hemorrhage Level of Intervention Pre-primary prophylaxis Primary prophylaxis Management Recommendations Repeat endoscopy in 2-3 years No specific therapy Small varices Repeat endoscopy in 1-2 years No specific therapy? beta-blocker to prevent enlargement Medium/Large varices Non-selective beta-blockers EVL in those intolerant to drugs Endoscopic/pharmacologic therapy Antibiotics in all patients TIPS or shunt surgery as rescue therapy
51 SUMMARY OF MANAGEMENT OF VARICES AND VARICEAL HEMORRHAGE Evolution of Varices Cirrhosis with no varices Small varices No hemorrhage Medium / large varices No hemorrhage Variceal hemorrhage Recurrent variceal hemorrhage Level of Intervention Pre-primary prophylaxis Primary prophylaxis Secondary prophylaxis Management Recommendations Repeat endoscopy in 2-3 years No specific therapy Small varices Repeat endoscopy in 1-2 years No specific therapy? beta-blocker to prevent enlargement Medium/Large varices Non-selective beta-blockers EVL in those intolerant to drugs Endoscopic/pharmacologic therapy Antibiotics in all patients TIPS or shunt surgery as rescue therapy Beta-blockers + EVL TIPS or shunt surgery as rescue therapy
52 Conclusion of the study TIPS did not increase survival rate compared with variceal band ligation It significantly reduced the incidence of variceal rebleeding without increasing the rate of encephalopathy.
53 PORTOSYSTEMIC SHUNTS Shunt operations are the only modalities that effectively reduce portal pressure and thus definatively treat the underlying cause of variceal bleeding. TYPES OF SHUNT OPERATIONS NON SELECTIVE SHUNTS Portocaval shunts Mesocaval shunts Splenorenal shunts SELECTIVE SHUNTS Distal splenorenal shunt
54 DISTAL SPLEENORENAL SHUNT
Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph
Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal
More informationVARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.
VARICEAL BLEEDING Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta Disclosures: None OUTLINE Pathophysiology of portal hypertension Splanchnic
More informationACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., 1 Arun J. Sanyal, M.D., 2 Norman D. Grace,
More informationPrimary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation
Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation Siwaporn Chainuvati, MD Faculty of Medicine Siriraj Hospital Outline Natural history of esophageal varices Which
More informationVariceal bleeding. Mainz,
Variceal bleeding Mainz, 21.09.2008 Risk of complications 5 years 10 years Ascites 10 % 25 % HCC 10 % 25 % Bleeding < 5 % 5-10 % Enceph. < 5 % < 5 % Typical situation : Mortality 10 % to 40 % Sequence
More informationBETA-BLOCKERS IN CIRRHOSIS.PRO.
BETA-BLOCKERS IN CIRRHOSIS.PRO. Angela Puente Sánchez. MD PhD Hepatology Unit. Gastroenterology department Marques de Valdecilla University Hospital. Santander INTRODUCTION. Natural history of cirrhosis
More informationManejo Actual del Sangrado por Varices Gástricas
Manejo Actual del Sangrado por Varices Gástricas Juan Carlos Garcia-Pagán Barcelona Hepatic Hemodynamic Laboratory. Liver Unit. IMDIM. Hospital Clinic. IDIBAPS. Ciberehd. XXIV Congreso de la Asociación
More informationth Annual AISF Meeting 44 th th th, 2011 Rome, February 23 rd -26
44 th 44 th Annual AISF Meeting Rome, February 23 rd -26 th th, 2011 Update on the Baveno Consensus Conference Roberto de Franchis Department of of Clinical Sciences, University of of Milan, Head, Gastroenterology
More informationGI bleeding in chronic liver disease
GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old
More informationTreatment of portal hypertension in the light of the Baveno VI Consensus Conference
r e v I E w A R T I C l e S Curierul medical, December 2015, Vol. 58, No 6 Treatment of portal hypertension in the light of the Baveno VI Consensus Conference E. Tcaciuc Department of Internal Medicine,
More informationMichele Bettinelli RN CCRN Lahey Health and Medical Center
Michele Bettinelli RN CCRN Lahey Health and Medical Center Differentiate the types of varices Identify glue preparations utilized when treating gastric varices Review the process of glue administration
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes
More informationCarvedilol or Propranolol in the Management of Portal Hypertension?
Evidence Based Case Report Carvedilol or Propranolol in the Management of Portal Hypertension? Arranged by: dr. Saskia Aziza Nursyirwan RESIDENCY PROGRAM OF INTERNAL MEDICINE DEPARTMENT UNIVERSITY OF INDONESIA
More informationCase Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France
Case Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France Thank you to Marika Rudler, Dominique Thabut, Adrian Gadano, and Jaime Bosch for
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute variceal bleeding management of, 251 262 balloon tamponade of esophagus in, 257 258 endoscopic therapies in, 255 257. See also Endoscopy,
More informationPortal hypertension is the main complication of cirrhosis
GASTROENTEROLOGY 2001;120:726 748 Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis GUADALUPE GARCIA TSAO
More informationPortogram shows opacification of gastroesophageal varices.
Portogram shows opacification of gastroesophageal varices. http://clinicalgate.com/radiologic-hepatobiliary-interventions/ courtesyhttp://emedicine.medscape.com/article/372708-overview DR.Thulfiqar Baiae
More informationDiagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion
5 th AISF Post-Meeting Course Diagnostic and Therapeutic Invasive Procedures in Hepatology Rome, February 25 th Diagnostic Procedures Measurement of Hepatic venous pressure in management of cirrhosis Clinician
More informationPrevention and treatment of variceal haemorrhage in 2017
Received: 12 October 2016 Accepted: 19 October 2016 DOI: 10.1111/liv.13277 REVIEW ARTICLE Prevention and treatment of variceal haemorrhage in 2017 Felix Brunner 1 Annalisa Berzigotti 1 Jaime Bosch 1,2
More informationIs pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis?
Controversies en Gastroenterology Is pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis? Rolando José Ortega Quiroz, MD, 1 Adalgiza
More informationA. Purpose and Scope of the Guidance PRACTICE GUIDANCE HEPATOLOGY, VOL. 65, NO. 1, 2017
AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES PRACTICE GUIDANCE HEPATOLOGY, VOL. 65, NO. 1, 2017 Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016
More informationBRTO /PARTO Indications and outcomes
BRTO /PARTO Indications and outcomes Saher Sabri, MD Associate Professor of Radiology and Surgery Division of Interventional Radiology University of Virginia Health System Saher Sabri, M.D. Speakers Bureau:
More informationVirtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,
More informationPatrick S. Kamath, MD, and David M. Nagorney, MD
gastrointestinal tract and abdomen PORTAL HYPERTENSION Patrick S. Kamath, MD, and David M. Nagorney, MD Portal hypertension is diagnosed when the hepatic veinpressure gradient (HVPG), which reflects hepatic
More informationUpper gastrointestinal bleeding in children. Nguyễn Diệu Vinh, MD Department of Gastroenterology
Upper gastrointestinal bleeding in children Nguyễn Diệu Vinh, MD Department of Gastroenterology INTRODUCTION Upper gastrointestinal (UGI) bleeding : arising proximal to the ligament of Treitz in the distal
More informationReview Article Self-Expandable Metal Stents in the Treatment of Acute Esophageal Variceal Bleeding
Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2011, Article ID 910986, 6 pages doi:10.1155/2011/910986 Review Article Self-Expandable Metal Stents in the Treatment of Acute
More informationPORTAL HYPERTENSION. Tianjin Medical University LIU JIAN
PORTAL HYPERTENSION Tianjin Medical University LIU JIAN DEFINITION Portal hypertension is present if portal venous pressure exceeds 10mmHg (1.3kPa). Normal portal venous pressure is 5 10mmHg (0.7 1.3kPa),
More informationBeta-blockers in cirrhosis: Cons
Beta-blockers in cirrhosis: Cons Eric Trépo MD, PhD Dept. of Gastroenterology. Hepatopancreatology and Digestive Oncology. C.U.B. Hôpital Erasme. Université Libre de Bruxelles. Bruxelles. Belgium Laboratory
More informationReview Article Role of Self-Expandable Metal Stents in Acute Variceal Bleeding
Hindawi Publishing Corporation International Journal of Hepatology Volume 2012, Article ID 418369, 6 pages doi:10.1155/2012/418369 Review Article Role of Self-Expandable Metal Stents in Acute Variceal
More informationMEDICAL PROGRESS. Review Article. N Engl J Med, Vol. 345, No. 9 August 30,
Review Article Medical Progress GASTROESOPHAGEAL VARICEAL HEMORRHAGE ALA I. SHARARA, M.D., AND DON C. ROCKEY, M.D. GASTROESOPHAGEAL variceal hemorrhage, a major complication of portal hypertension resulting
More informationManagement of Cirrhosis Related Complications
Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this
More informationManagement of variceal bleeding Rachael Harry, MA, MRCP, and Julia Wendon, FRCP
Management of variceal bleeding Rachael Harry, MA, MRCP, and Julia Wendon, FRCP Variceal hemorrhage complicates cirrhosis in as many as 50% of patients and results in considerable morbidity and mortality.
More informationClinical practice guidelines on the management of variceal bleeding
ecommons@aku Department of Medicine Department of Medicine January 2016 Clinical practice guidelines on the management of variceal bleeding Javed Iqbal Farooqi Hasnain Ali Shah Aga Khan University, hasnain.alishah@aku.edu
More informationSubject Review. Pathophysiology and Treatment of Variceal Hemorrhage M.D., AND PATRICK S. KAMATH, M.D.
Subject Review Pathophysiology and Treatment of Variceal Hemorrhage LEWIS R. ROBERTS, M.D., AND PATRICK S. KAMATH, M.D. Portal hypertension results from increases in portal flow and portal vascular resistance.
More informationTIPS. D Patch Royal Free Hospital London UK
TIPS D Patch Royal Free Hospital London UK TIPS Technique Ascites Budd Chiari Variceal Bleeding Historical Experimental Development 1967 Piccone Shunt between recanalized umbilical vein and saphenous
More informationRuptured duodenal varices arising from the main portal vein successfully treated with endoscopic injection sclerotherapy: a case report
The Korean Journal of Hepatology 2011;17:152-156 DOI: 10.3350/kjhep.2011.17.2.152 Case Report Ruptured duodenal varices arising from the main portal vein successfully treated with endoscopic injection
More informationComparison between Combination of Band ligation and Propranolol with Propranolol alone in Secondary Prophylaxis of Variceal bleed
ORIGINAL ARTICLE APMC 381 Comparison between Combination of Band ligation and Propranolol with Propranolol alone in Secondary Prophylaxis of Variceal bleed Muhammad Hanif, Amir Hussain, Muhammad Aamer,
More informationDecompensated chronic liver disease
Decompensated chronic liver disease Definition of decompensated chronic liver disease Patients with chronic liver disease can present with acute decompensation due to various causes. The decompensation
More informationLeft-sided portal hypertension with a patent splenic vein: An impossible or a not-so-uncommon scenario?
Khan et al. 108 CASE REPORT PEER REVIEWED OPEN ACCESS Left-sided portal hypertension with a patent splenic vein: An impossible or a not-so-uncommon scenario? Iftikhar Khan, Ghassan Ramahi, Saif Zaabi,
More informationComplication of Portal Hypertension: should the patients in the waiting list be treated differently?
Wilma Debernardi Venon Gastroepatologia, Az. Osp. San Giovanni Battista ditorino Complication of Portal Hypertension: should the patients in the waiting list be treated differently? Il sottoscritto dichiara
More informationLuis S. Marsano, MD March 2013
Portal HTN: Variceal Bleed, Portal Gastropathy, Hepatopulmonary Syndrome, Porto Pulmonary Hypertension, Cardiomyopathy, and Acute on Chronic Liver Failure Luis S. Marsano, MD March 2013 Variceal Hemorrhage
More informationContraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:
Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona
More informationCare of the Patient With Cirrhosis
REVIEW Care of the Patient With Cirrhosis Anitha Yadav, M.D., and Hugo E. Vargas, M.D. Caring for patients with cirrhosis involves multidisciplinary and timely management of several complications while
More informationREVIEW. Ariel W. Aday, M.D.,* Nicole E. Rich, M.D.,* Arjmand R. Mufti, M.D., and Shannan R. Tujios, M.D.
REVIEW CON ( The Window Is Closed ): In Patients With Cirrhosis With Ascites, the Clinical Risks of Nonselective beta-blocker Outweigh the Benefits and Should NOT Be Prescribed Ariel W. Aday, M.D.,* Nicole
More informationEtiology of liver cirrhosis
Liver cirrhosis 1 Liver cirrhosis Liver cirrhosis is the progressive replacement of normal hepatic cells by fibrous scar tissue, This scarring is accompanied by the loss of viable hepatocytes, which are
More informationTransjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy
CLINICAL IMAGES Ochsner Journal 17:311 316, 2017 Ó Academic Division of Ochsner Clinic Foundation Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy
More informationManagement of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide
Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications
More informationACUTE VARICEAL BLEEDING MULTIMODAL APPROACH
FALK symposium. Liver Cirrhosis: from pathophysiology to disease management Dresden, October 13-14 14 2007 ACUTE VARICEAL BLEEDING MULTIMODAL APPROACH Professor Andrew K Burroughs Hepato-biliary biliary-pancreatic
More informationThe Management of Ascites & Hepatorenal Syndrome. Florence Wong University of Toronto. Falk Symposium March 14, 2008
The Management of Ascites & Hepatorenal Syndrome Florence Wong University of Toronto Falk Symposium March 14, 2008 Management of Ascites Sodium Restriction Mandatory at all stages of ascites in order to
More informationJMSCR Vol 04 Issue 08 Page August 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i8.23 Portal Hypertension in Adults- A Comprehensive
More informationInitial approach to ascites
Ascites: Filling and Draining the Water Balloon Common Pathogenesis in Refractory Ascites, Hyponatremia, and Cirrhosis intrahepatic resistance sinusoidal portal hypertension Splanchnic vasodilation (effective
More informationTerlipressin: An Asset for Hepatologists!
DIAGNOSTIC AND THERAPEUTIC ADVANCES IN HEPATOLOGY Terlipressin: An Asset for Hepatologists! S.K. Sarin and Praveen Sharma One Case Scenario A 48-year-old male with alcoholic cirrhosis who was abstinent
More informationHemorragia por várices gastroesofágicas en la cirrosis
Hemorragia por várices gastroesofágicas en la cirrosis Referencias 1. Garcia-Tsao G, Sanyal AJ, Grace ND,Carey W, Practice Guidelines Committee of the American Association for the Study of Liver Diseases,
More informationManagement of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy
Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:
More informationCIRRHOSIS Definition
Cirrhosis Update Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Gastroenterology & Hepatology Weill Cornell Medical College CIRRHOSIS Definition Irreversible fibrous
More informationPortal hypertension and ascites
Portal hypertension and ascites Muhammad S Mirza Guruprasad P Aithal Abstract Portal pressure is the product of portal blood flow and resistance; an increase in either leads to increased portal pressure.
More informationV ariceal haemorrhage is a major cause of mortality and
270 LIVER DISEASE The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric : clinical and haemodynamic correlations D Tripathi, G Therapondos, E
More informationBarbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana
STROKOVNI SESTANEK ZDRUŽENJA HEMATOLOGOV SLOVENIJE IN ZDRUŽENJA ZA TRANSFUZIJSKO MEDICINO, Terme Zreče, 17.-18.4.2015 Barbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana goals,
More informationBeta-blocker plus nitrates for secondary prevention of variceal bleeding (Protocol)
Beta-blocker plus nitrates for secondary prevention of variceal bleeding (Protocol) Sharma BC, Gluud LL, Sarin SK This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration
More informationVariceal bleeding is a major cause of morbidity in patients
GASTROENTEROLOGY 2010;139:1238 1245 Equal Efficacy of Endoscopic Variceal Ligation and Propranolol in Preventing Variceal Bleeding in Patients With Noncirrhotic Portal Hypertension SHIV KUMAR SARIN,*,,
More informationPortal Hypertension and Variceal Bleeding: An AASLD Single Topic Symposium 1
Meeting Reports Portal Hypertension and Variceal Bleeding: An AASLD Single Topic Symposium 1 NORMAN D. GRACE, 1 ROBERTO J. GROSZMANN, 2 GUADALUPE GARCIA-TSAO, 2 ANDREW K. BURROUGHS, 3 LUIGI PAGLIARO, 4
More informationManagement of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University
Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments
More informationAscites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology
Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant
More informationGastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization
CASE REPORT Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization Takayuki Kogure, Jun Inoue, Eiji Kakazu, Masashi Ninomiya and Tooru Shimosegawa Abstract A 53-year-old
More informationRisk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis
Original Article Page 1 of 9 Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis Rui Sun*, Xingshun Qi* #, Deli Zou, Xiaodong Shao, Hongyu Li, Xiaozhong
More informationEditorial Process: Submission:07/25/2018 Acceptance:10/19/2018
RESEARCH ARTICLE Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018 Clinical Outcome and Predictive Factors of Variceal Bleeding in Patients with Hepatocellular Carcinoma in Thailand Jitrapa
More informationPractical Approach to Endoscopic Management for Bleeding Gastric Varices
Review Article http://dx.doi.org/10.3348/kjr.2012.13.s1.s40 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(S1):S40-S44 Practical Approach to Endoscopic Management for Bleeding Gastric Varices
More informationConflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.
Complications of end stage liver disease Conflict of interest disclosures None Amir Qamar, MD Instructor of Medicine Brigham and Women s s Hospital Harvard Medical School Boston, MA 02115 The many complications
More informationSurgical Rescue of Surgical Failures
HPB Surgery, 1999, Vol. 11, pp. 151-155 Reprints available directly from the publisher Photocopying permitted by license only (C) 1999 OPA (Overseas Publishers Association) N.V. Published by license under
More informationVariceal bleeding in cirrhotic patients
Gastroenterology Report, 5(3), 2017, 185 192 doi: 10.1093/gastro/gox024 Advance Access Publication Date: 21 July 2017 Review REVIEW Variceal bleeding in cirrhotic patients Maxime Mallet*, Marika Rudler,
More informationManaging Cirrhosis. Cirrhosis of the liver is a progressive, fibrosing. Ascites. By Cameron Ghent, MD, FRCPC. Complications of Cirrhosis
Focus on CME at the University of Western Ontario Managing Cirrhosis By Cameron Ghent, MD, FRCPC Cirrhosis of the liver is a progressive, fibrosing process resulting in nodule formation and microvascular
More informationEndovascular Techniques for Symptomatic Portal Hypertension. Michael Meuse, M.D. Vascular and Interventional Radiology
Endovascular Techniques for Symptomatic Portal Hypertension Michael Meuse, M.D. Vascular and Interventional Radiology Objectives Review indications and contraindications for TIPS Define a treatment algorithm
More informationUseful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation
Gut and Liver, Vol. 11, No. 6, November 2017, pp. 843-851 ORiginal Article Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after
More informationTranjugular Intrahepatic Portosystemic Shunt
Tranjugular Intrahepatic Portosystemic Shunt Christopher Selhorst July 25, 2005 BIDMC Radiology Overview Portal Hypertension Indications, Contraindications The Procedure Case Review Complications Outcomes
More informationUPPER GASTROINTESTINAL BLEEDING IN LIVER CIRRHOSIS PATIENTS
Archives of the Balkan Medical Union vol. 50, no. 4, pp. 543-547 Copyright 2015 CELSIUS December 2015 REVIEW UPPER GASTROINTESTINAL BLEEDING IN LIVER CIRRHOSIS PATIENTS CORINA SILVIA POP 1,2, ADINA PURCÃREANU
More informationTreatment of portal hypertension
Online Submissions: http://www.wjgnet.com/1007-9327office wjg@wjgnet.com doi:10.3748/wjg.v18.i11.1166 World J Gastroenterol 2012 March 21; 18(11): 1166-1175 ISSN 1007-9327 (print) ISSN 2219-2840 (online)
More informationSUMMARY AND CONCLUSION
- 100 - SUMMARY AND CONCLUSION The problem of portal hypertension and its alarming complications is still attracting the attentions of surgeons and physicians all over the world. Portal hypertension usually
More informationORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1129 1134 ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal
More informationOriginal Article INTRODUCTION. pissn eissn X
pissn 2287-2728 eissn 2287-285X Original Article Clinical and Molecular Hepatology 2016;22:466-476 Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active
More informationThe role of TIPS in the management of liver transplant candidates
Original Article The role of TIPS in the management of liver transplant candidates United European Gastroenterology Journal 217, Vol. 5(8) 11 117! Author(s) 217 Reprints and permissions: sagepub.co.uk/journalspermissions.nav
More informationCirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association
CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS
More informationProgram Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.
Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship
More informationThe role of endoscopy in the management of variceal hemorrhage
GUIDELINE The role of endoscopy in the management of variceal hemorrhage This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice
More informationRG Volume 33 Number 5 Kirby et al 1497
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. RG Volume 33 Number
More informationVariceal hemorrhage is a lethal complication of cirrhosis, particularly
T h e n e w e ngl a nd j o u r na l o f m e dic i n e review article Current Concepts Management of Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., and Jaime Bosch, M.D. Variceal
More informationCIRROSI E IPERTENSIONE PORTALE NELLA DONNA
Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di
More informationNoncirrhotic Portal Hypertension: Imaging, Hemodynamics, and Endovascular Therapy
REVIEW Noncirrhotic Portal Hypertension: Imaging, Hemodynamics, and Endovascular Therapy Venkatesh P. Krishnasamy, M.D.,* Michael J. Hagar, M.D., Albert K. Chun, M.D., M.B.A., and Elliot Levy, M.D. Patients
More informationControversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate
Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Patrick Northup, MD, FAASLD, FACG Medical Director, Liver Transplantation University of Virginia
More informationAustrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
Wien Klin Wochenschr (2017) 129 [Suppl 3]:S135 S158 https://doi.org/10.1007/s00508-017-1262-3 Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III) Thomas
More informationFollow this and additional works at:
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2017 Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde
More informationCost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding Raines D L, Dupont A W, Arguedas M R
Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding Raines D L, Dupont A W, Arguedas M R Record Status This is a critical abstract of an economic
More informationPortal hypertension Guadalupe Garcia-Tsao, MD
Portal hypertension Guadalupe Garcia-Tsao, MD Portal hypertension, the main complication of cirrhosis, is responsible for its most common complications: variceal hemorrhage, ascites, and portosystemic
More informationICU Volume 14 - Issue 2 - Summer Matrix
ICU Volume 14 - Issue 2 - Summer 2014 - Matrix Upper Gastrointestinal Bleeding Authors David Osman, MD Medical Intensive Care Unit Paris-South University Hospitals Assistance Publique-Hôpitaux de Paris
More informationNONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: THE THERAPEUTIC WINDOW
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2016 vol. 120, no. 1 INTERNAL MEDICINE UPDATES NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: THE THERAPEUTIC WINDOW Mihaela Dimache 1,2*, Irina Gîrleanu 1,2,
More informationAASLD PRACTICE GUIDELINE. The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Preamble.
AASLD PRACTICE GUIDELINE The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension Thomas D. Boyer 1 and Ziv J. Haskal 2 Preamble The recommendations in this article
More informationBRTO: Updates to Techniques
Session XIV: BRTO, PARTO and Portal Hypertension GEST2016 BRTO: Updates to Techniques Hiro Kiyosue Oita University Hospital, Japan Hiro Kiyosue, MD Royalty: Cook, Medkit Consulting Fee: Stryker Japan,
More informationORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:703 708 ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT Compliance With Practice Guidelines and Risk of a First Esophageal Variceal Hemorrhage in Patients
More informationEDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,
More informationDetection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters
ORIGINAL ARTICLE Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters Johana Prihartini*, LA Lesmana**, Chudahman Manan***, Rino A Gani** ABSTRACT Aim: recent guidelines recommend
More information